IL-7 sustains CD31 expression in human naive CD4+ T cells and preferentially expands the CD31+ subset in a PI3K-dependent manner

被引:60
作者
Azevedo, Rita I. [1 ]
Soares, Maria Vieira D. [1 ]
Barata, Joao T. [2 ]
Tendeiro, Rita [1 ]
Serra-Caetano, Ana [3 ]
Victorino, Rui M. M. [1 ]
Sousa, Ana E. [1 ]
机构
[1] Univ Lisbon, Fac Med Lisboa, Inst Mol Med, Unidad Imunol clin, P-1649028 Lisbon, Portugal
[2] Univ Lisbon, Fac Med Lisboa, Inst Mol Med, Unidad Biol Cancro, P-1649028 Lisbon, Portugal
[3] Univ Lisbon, Fac Med Lisboa, Inst Mol Med, Unidad Citometria Fluxo, P-1649028 Lisbon, Portugal
关键词
RECENT THYMIC EMIGRANTS; BONE-MARROW-TRANSPLANTATION; IN-VIVO; HOMEOSTATIC PROLIFERATION; TCR REPERTOIRE; EXPANSION; SURVIVAL; ACTIVATION; RECEPTOR; INTERLEUKIN-7;
D O I
10.1182/blood-2008-07-166223
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The CD31(+) subset of human naive CD4(+) T cells is thought to contain the population of cells that have recently emigrated from the thymus, while their CD31(-) counterparts have been proposed to originate from CD31(+) cells after homeostatic cell division. Naive T-cell maintenance is known to involve homeostatic cytokines such as interleukin-7 (IL-7). It remains to be investigated what role this cytokine has in the homeostasis of naive CD4(+) T-cell subsets defined by CD31 expression. We provide evidence that IL-7 exerts a preferential proliferative effect on CD31(+) naive CD4(+) T cells from adult peripheral blood compared with the CD31(+) subset. IL-7-driven proliferation did not result in loss of CD31 expression, suggesting that CD31(+) naive CD4(+) T cells can undergo cytokine-driven homeostatic proliferation while preserving CD31. Furthermore, IL-7 sustained or increased CD31 expression even in nonproliferating cells. Both proliferation and CD31 maintenance were dependent on the activation of phosphoinositide 3-kinase (PI3K) signaling. Taken together, our data suggest that during adulthood CD31(+) naive CD4(+) T cells are maintained by IL-7 and that IL-7-based therapies may exert a preferential effect on this population. (Blood. 2009; 113: 2999-3007)
引用
收藏
页码:2999 / 3007
页数:9
相关论文
共 40 条
[1]   Rate of increase in circulating IL-7 and loss of IL-7Rα expression differ in HIV-1 and HIV-2 infections:: Two lymphopenic disease with similar hyperimmune activation but distinct outcomes [J].
Albuquerque, Adriana S. ;
Cortesao, Catarina S. ;
Foxall, Russell B. ;
Soares, Rui S. ;
Victorino, Rui M. M. ;
Sousa, Ana E. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (05) :3252-3259
[2]   IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation [J].
Alpdogan, Ö ;
Muriglan, SJ ;
Eng, JM ;
Willis, LM ;
Greenberg, AS ;
Kappel, B ;
van den Brink, MRM .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07) :1095-1107
[3]   Molecular and functional evidence for activity of murine IL-7 on human lymphocytes [J].
Barata, Joao T. ;
Silva, Ana ;
Abecasis, Miguel ;
Carlesso, Nadia ;
Cumano, Ana ;
Cardoso, Angelo A. .
EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) :1133-1142
[4]   Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells [J].
Barata, JT ;
Silva, A ;
Brandao, JG ;
Nadler, LM ;
Cardoso, AA ;
Boussiotis, VA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (05) :659-669
[5]   Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count [J].
Bolotin, E ;
Annett, G ;
Parkman, R ;
Weinberg, K .
BONE MARROW TRANSPLANTATION, 1999, 23 (08) :783-788
[6]   Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants [J].
Broers, AEC ;
Posthumus-van Sluijs, SJ ;
Spits, H ;
van der Holt, B ;
Löwenberg, B ;
Braakman, E ;
Cornelissen, JJ .
BLOOD, 2003, 102 (04) :1534-1540
[7]   T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation [J].
Crawley, JB ;
Rawlinson, L ;
Lali, FV ;
Page, TH ;
Saklatvala, J ;
Foxwell, BMJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :15023-15027
[8]  
Deaglio S, 1998, J IMMUNOL, V160, P395
[9]   CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells [J].
Demeure, CE ;
Byun, DG ;
Yang, LP ;
Vezzio, N ;
Delespesse, G .
IMMUNOLOGY, 1996, 88 (01) :110-115
[10]  
DITTEL BN, 1995, J IMMUNOL, V154, P58